Publications
Below you will find links to several abstracts that pertain to our research:
-
Use of Magnesium in Traumatic Brain Injury, Published by The Journal of the American Society of Experimental NeuroTherapeutics
Use of Magnesium in Traumatic Brain InjurySen, Ananda P. and Gulati, Anil
-
ET-11: APS International Conference on Endothelin, 5.15, 2009
ET receptor Antagonists in the Treatment of Diabetic KetoacidosisGulati A, Lavhale M, Koenig K, Havalad S
-
Pharmacology 83(1):45-58, 2009.
Determination of adrenergic and imidazoline receptor involvement in augmentation of morphine and oxycodone analgesia by clonidine and BMS182874.Gulati A, Bhalla S, Matwyshyn G, Zhang Z, Andurkar SV.
-
Prostate 67(7):701-13, 2007.
IRL-1620, a tumor selective vasodilator, augments the uptake and efficacy of chemotherapeutic agents in prostate tumor rats.Rajeshkumar NV, Matwyshyn G, Gulati A.
-
Methods and Findings in Experimental and Clinical Pharmacology 29(4):257-63, 2007.
Effect of combination of endothelin receptor antagonist (TAK-044) and aspirin in middle cerebral artery occlusion model of acute ischemic stroke in rats.Briyal S, Gulati A, Gupta YK.
-
Experimental Biology and Medicine (Maywood, N.J.) 231(6):1152-6, 2006.
Involvement of endothelin in morphine tolerance in neuroblastoma (SH-SY5Y) cells.Bhalla S, Ciaccio N, Wang ZJ, Gulati A.
-
European Journal of Pharmacology 43(1-3):48-53, 2006.
Endothelin ETA receptor blockade potentiates morphine analgesia but does not affect gastrointestinal transit in mice.Matwyshyn GA, Bhalla S, Gulati A.
-
Experimental Biology and Medicine (Maywood, N.J.) 231(6):1120-2, 2006.
Effect of the ET(B) receptor agonist, IRL-1620, on paclitaxel plasma pharmacokinetics of breast tumor rats.Rai A, Rajeshkumar NV, Gulati A.
-
Breast Cancer Research and Treatment 94(3):237-47, 2005.
Endothelin B receptor agonist, IRL 1620, enhances the anti-tumor efficacy of paclitaxel in breast tumor rats.Rajeshkumar NV, Rai A, Gulati A.
-
Life Sciences 77(1):15-27, 2005.
Effect of endothelin antagonist (TAK-044) on cerebral ischemic volume, oxidative stress markers and neurobehavioral parameters in the middle cerebral artery occlusion model of stroke in rats.Gupta YK, Briyal S, Sharma U, Jagannathan NR, Gulati A.
-
Brain Research 1064(1-2):126-35, 2005.
Morphine tolerance does not develop in mice treated with endothelin-A receptor antagonists.Bhalla S, Matwyshyn G, Gulati A.
-
Journal of Pharmacy and Pharmacology 57(7):869-76, 2005.
ET(B) receptor agonist, IRL 1620, does not affect paclitaxel plasma pharmacokinetics in breast tumour bearing rats.Rai A, Rajeshkumar NV, Shord S, Gulati A.
-
Pharmacology 72(1):20-5, 2004.
Central endothelin-B receptor stimulation does not affect morphine analgesia in rats.Bhalla S, Matwyshyn G, Gulati A.
-
Journal of Cardiovascular Pharmacology 44 (Suppl 1):S483-6, 2004
Endothelin-1-induced vasodilatation in rat breast tumor is mediated through endothelin-B receptors.Gulati A, Rai A.
-
Journal of Pharmacy and Pharmacology 56(2):271-5, 2004.
Endothelin ETA receptor antagonist did not affect development of tolerance to glyceryl trinitrate in rat.Rai A, Bhalla S, Gulati A.
-
Journal of Cardiovascular Pharmacology 44 (Suppl 1):S129-31, 2004.
A novel combination of opiates and endothelin antagonists to manage pain without any tolerance development.Gulati A, Bhalla S, Matwyshyn G.
-
Peptides 24(4):553-61, 2003.
Endothelin receptor antagonists restore morphine analgesia in morphine tolerant rats.Bhalla S, Matwyshyn G, Gulati A.
-
Cancer Chemotherapy and Pharmacology 51(1):21-8, 2003.
Evidence for the involvement of ET(B) receptors in ET-1-induced changes in blood flow to the rat breast tumor.Rai A, Gulati A.
-
Peptides 23(10):1837-45., 2002
Potentiation of morphine analgesia by BQ123, an endothelin antagonist.Bhalla S, Matwyshyn G, Gulati A.


